Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DU-176b Phase IIb VTE prevention after total hip replacement
jRCT2080220798Phase 2
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of edoxaban in venous thromboembolism (VTE) (2 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on jRCT2080220798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220798.